ELAN News and Press, Elanco Animal Health Incorporated From 10/19/23

2023-10-19 11:39:51 ET More on AbbVie, Eli Lilly, etc. AbbVie: The Humira Loss May Be Fully Priced In After All AbbVie: Q2 Success Sets The Stage For Consistent Growth AbbVie: Why You Should Pay Attention To This High-Yielding Dividend King (Rating Downgrade) ...

Elanco Animal Health Incorporated (NYSE: ELAN) will announce its third quarter 2023 financial results on Tuesday, November 7, 2023. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance. The conference...

2023-10-06 15:44:32 ET More on Elanco, IDEXX, etc. Elanco Animal Health: Signs Of Stabilization, Amidst Still A Big Debt Pile Zoetis Is An Impressive Healthcare Compounder IDEXX Laboratories: Long-Term Growth Remains Attractive Elanco pushes for governance ch...

2023-10-06 07:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-10-05 08:24:37 ET Summary Elanco Animal Health has struggled with revenue declines and high debt load in a challenging environment. The company's leverage ratios remain high despite efforts to stabilize the business and control leverage. Elanco's guidance for 2023 was dis...

2023-10-04 06:56:07 ET More on Elanco Elanco Animal Health Incorporated (ELAN) Q2 2023 Earnings Call Transcript Elanco Animal Health Incorporated 2023 Q2 - Results - Earnings Call Presentation Elanco Animal Health: Seems Like A Decent Bet Right Now Elanco spi...

Elanco Animal Health Incorporated (NYSE: ELAN) announced today that the Board of Directors has commenced a process to amend the Company’s corporate governing documents as part of a comprehensive governance review following the Company’s 2023 Annual Meeting of Shareholders. The Board...

Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced that the first shipments of Varenzin™-CA1 (molidustat oral suspension), conditionally approved by U.S. Food and Drug Administration (FDA) as the first and only treatment to control non-regenerative anemia in cats with chronic ...

2023-09-07 14:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11, 2023 and Tuesday, September 12, 2023. Jeff Simmons, president and CEO, will participate in a fireside chat on Monday at 4:15 p.m. ET. A live audio we...